Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2003 | 12-2002 | 09-2002 | 06-2002 | 03-2002 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 4,665,000 | 9,126,000 | 6,270,000 | 3,920,000 | 1,963,000 |
| Depreciation Amortization | 269,000 | 1,030,000 | 736,000 | 486,000 | 246,000 |
| Income taxes - deferred | 22,000 | -285,000 | N/A | N/A | N/A |
| Accounts receivable | N/A | -963,000 | N/A | N/A | N/A |
| Other Working Capital | 961,000 | 314,000 | -939,000 | -636,000 | -1,079,000 |
| Other Operating Activity | -3,594,000 | 642,000 | 194,000 | 221,000 | 361,000 |
| Operating Cash Flow | $2,323,000 | $9,864,000 | $6,261,000 | $3,991,000 | $1,491,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -2,568,000 | -2,871,000 | -3,009,000 | -2,457,000 | -944,000 |
| PPE Investments | -382,000 | -1,758,000 | -1,172,000 | -801,000 | -369,000 |
| Net Acquisitions | 1,178,000 | 220,000 | 6,000 | 5,000 | 5,000 |
| Purchase Of Investment | -356,000 | -2,877,000 | -2,533,000 | -1,338,000 | -902,000 |
| Sale Of Investment | 182,000 | 3,477,000 | 2,907,000 | 1,800,000 | 1,240,000 |
| Other Investing Activity | 63,000 | -529,000 | 99,000 | -112,000 | -60,000 |
| Investing Cash Flow | $-1,883,000 | $-4,338,000 | $-3,702,000 | $-2,903,000 | $-1,030,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 919,000 | 2,815,000 | 4,657,000 | 2,090,000 | 1,650,000 |
| Debt Issued | 600,000 | 603,000 | 600,000 | 599,000 | 1,000 |
| Debt Repayment | -256,000 | -374,000 | -212,000 | -6,000 | -6,000 |
| Common Stock Issued | 78,000 | 660,000 | 549,000 | 332,000 | 143,000 |
| Common Stock Repurchased | -598,000 | -4,996,000 | -4,726,000 | -1,996,000 | -1,048,000 |
| Dividend Paid | -906,000 | -3,168,000 | -2,382,000 | -1,594,000 | -798,000 |
| Other Financing Activity | -89,000 | -539,000 | -442,000 | -441,000 | -157,000 |
| Financing Cash Flow | $-252,000 | $-4,999,000 | $-1,956,000 | $-1,016,000 | $-215,000 |
| Exchange Rate Effect | -12,000 | -4,000 | -4,000 | 1,000 | 6,000 |
| Beginning Cash Position | 1,878,000 | 1,036,000 | 1,036,000 | 1,036,000 | 1,036,000 |
| End Cash Position | 2,068,000 | 1,878,000 | 1,774,000 | 1,196,000 | 1,332,000 |
| Net Cash Flow | $190,000 | $842,000 | $738,000 | $160,000 | $296,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 2,323,000 | 9,864,000 | 6,261,000 | 3,991,000 | 1,491,000 |
| Capital Expenditure | -382,000 | -1,758,000 | -1,172,000 | -801,000 | -369,000 |
| Free Cash Flow | 1,941,000 | 8,106,000 | 5,089,000 | 3,190,000 | 1,122,000 |